News
Two top companies managing prescription drug benefits in the US are fighting to keep Hawaii’s lawsuit against them in federal ...
The House and Senate will need to reconcile their versions of the bill for it to become law — something that has eluded the ...
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...
Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...
Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...
Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...
CVS Health (CVS) is one of the largest healthcare companies in the country, boasting a vertically integrated business that ...
A fairly common scene from childhood— my mother furiously rocking in her chair, the phone cord stretched to its limit, grinding a hole into the floral wallpaper as she sparred with some health ...
Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...
Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results